Aug 30, 2017
International Telepathology and Frozen Section Consultations Using Digital Pathology
Dr. Jianyu Rao, Professor of Pathology and Epidemiology, Director, Cytopathology Division, Director, International Telepathology, Ronald Reagan Medical Center, UCLA Health
OptraSCAN’s Pre-Conference Workshop at Pathology Visions 2017 – Sunday Oct 1, 2:30-3:00 pm
The increase in cancer rates, shortage of pathologists and limited resources in remote areas, create a global burden on the pathology system. In this presentation, we’ll discuss how the UCLA Health system established an international telepathology system to aid pathologists and patients in China. We’ll also discuss how new technologies, such as OptraSCAN On-Demand Digital Pathology, can enable international and domestic telepathology networks to attain lower turn-around times for secondary consults, remote frozen sections review, and better overall outcomes for pathologists and patients.
Dr. J Rao is a diagnostic surgical/cytopathologist and established investigator in cancer biomarker studies. Prior to becoming a pathologist, he was an established molecular epidemiologist involved in multiple high profile cancer prevention studies. He completed his anatomic/clinical pathology residency and cytopathology fellowship at UCLA, and joined the UCLA Department of Pathology as a faculty member in 1999. Dr. J. Rao is a full professor and the chief of Cytopathology, ex-director of gynecological pathology, the director of international telepathology, and the medical director of the cytotechnology school. He has dual appointments in pathology and epidemiology. He is also a recipient of the Thousand-Talent program of China. He is particularly well known for cancer biomarker studies, as he has over 30 years experience in this area. He has been invited to be a speaker for over 100 meetings and occasions locally, nationally and internationally for topics including urine cytology, Fine Needle Aspiration cytology, gynecological pathology, and cancer molecular biomarkers. Dr. Rao has an active role in teaching and research, with continuous funding from NIH or other agencies for cancer biomarker and prevention studies in the last 25 years, with over 140 peer-reviewed research publications.